Gilead sees transaction with Tentarix to reduce EPS by 3c-4c

Beginning in the first quarter of 2022, consistent with recent industry communications from the U.S. Securities and Exchange Commission SEC , Gilead no longer excludes acquired IPR&D expenses from its non-GAAP financial measures. Gilead see the transaction with Tentarix to reduce Gilead’s GAAP and non-GAAP 2023 EPS by approximately 3c-4c.